|
|
Cytogenetic analysis of amniotic fluid on 4 943 high-risk pregnant women |
CHEN Yangping1, XU Feng1, TANG Shaohua2, XU Xueqin2 |
1.Department of Obstetrics and Gynecology, Wenzhou Central Hospital, Wenzhou 325000, China; 2.Center of Prenatal Diagnosis, Wenzhou Central Hospital, Wenzhou 325000, China |
|
Cite this article: |
CHEN Yangping,XU Feng,TANG Shaohua, et al. Cytogenetic analysis of amniotic fluid on 4 943 high-risk pregnant women[J]. JOURNAL OF WEZHOU MEDICAL UNIVERSITY, 2019, 49(10): 756-759.
|
|
Abstract Objective: To explore how different prenatal diagnostic indications are related to the frequency and type of abnormal karyotype of amniotic fluid cells in high-risk pregnant women. Methods: A retrospective analysis was made on the clinical data of 4943 cases receiving prenatal diagnosis because of various risk factors in our hospital. Results: A total of 182 cases were diagnosed as chromosomal abnormalities, with the detection rate being 3.68%. The highest abnormality rate was 90.47% in the non-invasive DNA high-risk group, and in the other 12 cases the abnormality rate was 75% after amniocentesis due to non-invasive DNA indicated sex chromosomal abnormalities. The abnormal rate was 7.61% in the ultrasound abnormal group, 3.43% in the elderly group, 3.09% in the down-screening 21-trisomy high-risk group, 2.28% in the down-screening 18-trisomy high-risk group, and 0.37% in the adverse pregnancy history group. The non-invasive DNA high-risk group had the highest chromosomal abnormality rate, followed by the ultrasound abnormality group. Conclusion: The non-invasive DNA could not completely replace the amniotic fluid cell karyotype analysis, which was considered the gold standard for detecting the fetal chromosomal abnormality. The fetal chromosomes in elderly pregnant women were prone to mutations. It is recommended that prenatal diagnosis be performed directly, and meanwhile, extra gene chips are recommended for those with ultrasound abnormalities or the elderly pregnant women.
|
Received: 27 February 2019
|
|
|
|
|
[1] 罗云玲, 朱丹玲, 马健, 等. 2008-2017年深圳市第二人民医院出生缺陷检监测结果分析[J]. 深圳中西医结合杂志, 2018, 28(13): 4-6.
[2] 中华人民共和国卫生部, 中国残疾人联合会. 中国提高出生人口素质、减少出生缺陷和残疾行动计划(2002-2010)[J]. 中国生育健康杂志, 2002, 13(3): 98-101.
[3] 李胜利. 胎儿畸形产前超声诊断学[M]. 北京: 人民军医出版社, 2004: 559-589.
[4] 金克勤, 程妙鸳, 沈双双, 等. 2605份孕中期羊水细胞染色体核型分析[J]. 中华医学遗传学杂志, 2017, 34(2): 307-309.
[5] 吴小青, 李英, 谢晓蕊, 等. 3 240名高龄孕妇胎儿染色体核型分析, 中华医学遗传学杂志[J]. 2014, 31(2): 255-257.
[6] Committee Opinion Summary No. 640: Cell-Free Dna Screening For Fetal Aneuploidy[J]. Obstet Gynecol, 2015, 126(3): 691-692.
[7] NICOLAIDES K H, SNIJDER R J M, GOSDEN R J M, et al.
Ultrasonographically detectable markers of fetal chromosomal abnormalities[J]. Lancet, 1992, 340(8821): 704-707.
[8] GEDIKBASI A, OZTARHANK K, ASLAN G, et al. Multidisciplinary approach in cystic hygroma:prenatal diagnosis, outcome, and postnatal follow up[J]. Pediatr Int, 2009, 51(1): 670-677.
[9] SHEN S, YUAN L, ZENG S. An effort to test the embryotoxicity of benzene, toluene, xylene, and formaldehyde to murine embryonicstem cells using airborne exposure tech-nique[J]. Inhal Toxicol, 2009, 21(12): 973-978.
[10] 吴成秋, 李纯颖, 李梓民, 等. 苯与甲醛对小鼠胚胎的联合毒性效应研究[J]. 癌变·畸变·突变, 2009, 21(6): 455-459.
[11] REDON R, ISHIKAWA S, FITCH K R, et al. Global variation in copy number in the human genome[J]. Nature, 2006, 444(7118): 444-454.
[12] STRASSBERG M, FRUHMAN G, VAN DEN VEYVER I B. Copy-number changes in prenatal diagnosis[J]. Expert Rev Mol Diagn, 2011, 11(6): 579-592. |
|
|
|